News Digest / Ticker: PLX

Ticker: PLX

09:49am, Friday, Oct 17, 2025

Protalix Shares Dive Over EMA's Negative Take on Elfabrio's New Dosing Plan

Protalix BioTherapeutics (NYSE American: PLX) sees stock tumble after EMA's CHMP rejects alternative dosing regimen for Elfabrio in Fabry disease treatment.

08:14am, Thursday, Aug 14, 2025

Protalix posts revenue surge, narrows operating loss but R&D spend and cash burn rise

08:05am, Friday, May 09, 2025

Protalix BioTherapeutics Reports 170% Revenue Surge Amid Rising Costs and Ongoing Challenges